Product Information
OSELTAMIVIR 6 MG/ML SUSPENSION is a generic product labeled by Strides Pharma Inc., priced at $0.1575 per ML under NDC 64380087975. Its NADAC has been published 143 times since Nov 30, 2022.
FDA first approved this application on Jan 13, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
6 mg/mL
Manufacturer
Strides Pharma Inc.NDC
64380087975
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA211894FDA Approved
1/13/2022
TE Code
AB
On Market Since
10/24/2022
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has been published 143 times since Nov 30, 2022, and over the history we have for it it has declined 60.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1575 per ML |
|---|---|
| All-time high | $0.3998 (Dec 14, 2022) |
| All-time low | $0.1271 (Nov 20, 2024) |
| 52-week high | $0.1739 |
| 52-week low | $0.1497 |
| Median price | $0.1982 |
| Average price | $0.2178 |
| Largest weekly change | +38.5% (Dec 18, 2024) |
| Weeks tracked | 143 |
| Tracking since | Nov 30, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
+5.2%
1Y
-9.4%
3Y
-53.5%
5Y
N/A
All
-60.6%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oseltamivir Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Neuraminidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR 6 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR 6 MG/ML SUSPENSION, manufactured by Strides Pharma Inc., is $0.1575 per ML (NDC 64380087975), effective May 20, 2026.
How has the price of OSELTAMIVIR 6 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has declined 60.6%. It has been tracked across 143 weekly CMS publications since Nov 30, 2022.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR 6 MG/ML SUSPENSION?
Since Nov 30, 2022, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has ranged from a low of $0.1271 (Nov 20, 2024) to a high of $0.3998 (Dec 14, 2022), with a median of $0.1982 per ML.
Are there cheaper alternatives to OSELTAMIVIR 6 MG/ML SUSPENSION?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OSELTAMIVIR 6 MG/ML SUSPENSION, is $0.1496 per ML — about 5% below OSELTAMIVIR 6 MG/ML SUSPENSION.
Who manufactures OSELTAMIVIR 6 MG/ML SUSPENSION?
OSELTAMIVIR 6 MG/ML SUSPENSION (NDC 64380087975) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.